Ombitasvir
Generic Name: ombitasvir
Manufactured by ABBVIE. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 200MG BASE); OMBITASVIR (8.33MG); PARITAPREVIR (50MG); RITONAVIR (33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA208624.
Overview
Manufactured by ABBVIE. Dosage form: TABLET, EXTENDED RELEASE. Route: ORAL. Active ingredients: DASABUVIR SODIUM (EQ 200MG BASE); OMBITASVIR (8.33MG); PARITAPREVIR (50MG); RITONAVIR (33.33MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**). Application: NDA208624.
Dosage
Available as tablet, extended release for oral use.
Related Medications
Tocilizumab-anoh
tocilizumab-anoh
Manufactured by CELLTRION INC. Dosage form: INJECTABLE. Route: IV (INFUSION). Active ingredients: TOCILIZUMAB-ANOH (200MG/10ML(20MG/ML)). Application: BLA761498.
Menthol And Pectin
menthol and pectin
Purpose Pectin: oral demulcent Menthol: cough suppressant, oral anesthetic
Platanus Occidentalis Pollen
platanus occidentalis pollen
Dosage form: INJECTION, SUSPENSION. Route: SUBCUTANEOUS. Active ingredients: PLATANUS OCCIDENTALIS POLLEN (10000 [PNU]/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.